Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073122 · ClinicalTrials.gov registry record
The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 127
- Enrollment target
NCT03073122: Completed study, sponsored by Boston Children's Hospital.
NCT03073122 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03073122 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
In the landmark Boston Circulatory Arrest Study, neurologic and developmental status was measured following infant heart surgery and then prospectively at ages 1, 2.5, 4, 8, and 16 years, with findings of significant neurocognitive deficits and brain MRI abnormalities regardless of operative management. To date, no study has evaluated the neuropsychological and neuroimaging antecedents and correlates of well-being in adults with congenital heart disease, a population now \>1 million and projected to grow at 5% per year. The investigators propose to study the Boston cohort at ages 24-29 years to assess the associations of adult well-being with childhood and adolescent executive function, other measures of mental health and cognitive function, adolescent brain MRI findings, and clinical variables; findings will guide the design of interventions in childhood to optimize outcomes in adults with congenital heart disease.
Primary Outcome
Linear analog scale, Quality of Life Survey
Interventions
- DIAGNOSTIC_TEST Brain MRI, neurocognitive and psychological testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2023-01-31 |
What the finished NCT03073122 record still lists
NCT03073122 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Brain MRI, neurocognitive and psychological testing is the first listed.
NCT03073122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03073122 about?
NCT03073122 is a clinical study titled "The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease". In the landmark Boston Circulatory Arrest Study, neurologic and developmental status was measured following infant heart surgery and then prospectively at ages 1, 2.5, 4, 8, and 16 years, with findings of significant neurocognitive deficits and brain MRI abnormalities regardless of operative managem...
What is the current status of trial NCT03073122?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2017-11-09. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03073122?
The interventions under investigation include: Brain MRI, neurocognitive and psychological testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03073122?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI